Avenue Therapeutics (ATXI) AGM 2025 summary

Opening remarks and agenda

• CEO Alexandra MacLean called the 2025 Annual Meeting of Stockholders to order and introduced the board members present via remote communication.

• The meeting was held virtually, with instructions for stockholder participation and question submission provided.

Board and executive committee updates

• Directors up for election included Jay Kranzler, Faith Charles, Neil Herskowitz, Alexandra MacLean, Curtis Oltmans, and Lindsay A. Rosenwald.

Overview of voting outcomes

• A quorum was confirmed as present, allowing the meeting to proceed.

• All nominated directors were elected to serve until the 2026 Annual Meeting or until successors are elected.

• The appointment of KPMG LLP as independent registered public accounting firm for the 2025 fiscal year was ratified.